{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:25:39Z","timestamp":1790663139342,"version":"4.1.0"},"reference-count":130,"publisher":"Xia & He Publishing","issue":"X","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,28]]},"DOI":"10.14218\/jcth.2018.00049","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T07:42:01Z","timestamp":1555918921000},"page":"1-11","source":"Crossref","is-referenced-by-count":61,"title":["HCV Extrahepatic Manifestations"],"prefix":"10.14218","volume":"7","author":[{"given":"Lucija","family":"Kuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Smolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Smolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2019,4,21]]},"reference":[{"key":"key20190422074157_b1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0961203314556140","article-title":"Extrahepatic manifestations in chronic hepatitis C virus carriers","volume":"24","author":"Rosenthal","year":"2015","journal-title":"Lupus"},{"key":"key20190422074157_b2","first-page":"3","article-title":"A brief update on the treatment of hepatitis C","author":"Austria","year":"2017","journal-title":"Update on hepatitis C. IntechOpen"},{"key":"key20190422074157_b3","first-page":"111","article-title":"Extrahepatic Manifestations of Hepatitis C Virus Infection","author":"Virovic Jukic","year":"2017","journal-title":"Update on hepatitis C. IntechOpen"},{"key":"key20190422074157_b4","first-page":"87","article-title":"Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection","volume":"19","author":"Flores-Ch\u00e1vez","year":"2017","journal-title":"Rev Esp Sanid Penit"},{"key":"key20190422074157_b5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"key20190422074157_b6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0168-8278(98)80270-5","article-title":"Hepatitis C virus infection and cryoglobulinemia","volume":"29","author":"Lunel","year":"1998","journal-title":"J Hepatol"},{"key":"key20190422074157_b7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.1840190407","article-title":"Immunological disorders in C virus chronic active hepatitis: a prospective case-control study","volume":"19","author":"Pawlotsky","year":"1994","journal-title":"Hepatology"},{"key":"key20190422074157_b8","first-page":"2199","article-title":"Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus","volume":"31","author":"Sene","year":"2004","journal-title":"J Rheumatol"},{"key":"key20190422074157_b9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cgh.2010.08.026","article-title":"Manifestations of chronic hepatitis C virus infection beyond the liver","volume":"8","author":"Jacobson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20190422074157_b10","first-page":"6518","article-title":"Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients","volume":"13","author":"Stefanova-Petrova","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20190422074157_b11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MNH.0b013e3282f8afe2","article-title":"Cryoglobulinemia and renal disease","volume":"17","author":"Alpers","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20190422074157_b12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"key20190422074157_b13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","article-title":"Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis","volume":"63","author":"Terrier","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key20190422074157_b14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.humimm.2013.08.273","article-title":"Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia","volume":"74","author":"Jab\u0142o\u0144ska","year":"2013","journal-title":"Hum Immunol"},{"key":"key20190422074157_b15","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2015.364","article-title":"Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders","volume":"35","author":"Dai","year":"2016","journal-title":"Oncogene"},{"key":"key20190422074157_b16","doi-asserted-by":"crossref","first-page":"13882","DOI":"10.1038\/ncomms13882","article-title":"Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"key":"key20190422074157_b17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/annonc\/mdx635","article-title":"From hepatitis C virus infection to B-cell lymphoma","volume":"29","author":"Couronn\u00e9","year":"2018","journal-title":"Ann Oncol"},{"key":"key20190422074157_b18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"key20190422074157_b19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","article-title":"Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood"},{"key":"key20190422074157_b20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","article-title":"Infection of peripheral mononuclear blood cells by hepatitis C virus","volume":"15","author":"Zignego","year":"1992","journal-title":"J Hepatol"},{"key":"key20190422074157_b21","doi-asserted-by":"crossref","first-page":"980942","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"key20190422074157_b22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"key20190422074157_b23","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key20190422074157_b24","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"key":"key20190422074157_b25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"key":"key20190422074157_b26","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2013-10-532895","article-title":"B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"key20190422074157_b27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/asheducation-2014.1.590","article-title":"Hepatitis C virus-associated B-cell non-Hodgkin lymphomas","volume":"2014","author":"Vannata","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20190422074157_b28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"key":"key20190422074157_b29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1572-0241.2005.40429.x","article-title":"Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study","volume":"100","author":"Zein","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"key20190422074157_b30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2337\/dc05-1995","article-title":"Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis","volume":"29","author":"Lecube","year":"2006","journal-title":"Diabetes Care"},{"key":"key20190422074157_b31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/rheumatology\/keh011","article-title":"Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients","volume":"43","author":"Antonelli","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"key20190422074157_b32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"key":"key20190422074157_b33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2893.2011.01554.x","article-title":"Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity","volume":"19","author":"Stepanova","year":"2012","journal-title":"J Viral Hepat"},{"issue":"Suppl 2","key":"key20190422074157_b34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12072-013-9460-1","article-title":"Insulin resistance, steatosis and hepatitis C virus","volume":"7","author":"Mangia","year":"2013","journal-title":"Hepatol Int"},{"key":"key20190422074157_b35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"key20190422074157_b36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diabres.2006.07.008","article-title":"Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III]","volume":"75","author":"Shaheen","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"key20190422074157_b37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"key20190422074157_b38","doi-asserted-by":"crossref","first-page":"e38522","DOI":"10.1371\/journal.pone.0038522","article-title":"Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"key20190422074157_b39","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.2337\/diabetes.51.2007.S405","article-title":"Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes","volume":"51","author":"Prentki","year":"2002","journal-title":"Diabetes"},{"key":"key20190422074157_b40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.arcmed.2005.01.003","article-title":"Pathogenesis of type 2 diabetes mellitus","volume":"36","author":"Leahy","year":"2005","journal-title":"Arch Med Res"},{"key":"key20190422074157_b41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.autrev.2016.09.006","article-title":"International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement","volume":"15","author":"Ferri","year":"2016","journal-title":"Autoimmun Rev"},{"key":"key20190422074157_b42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhep.2008.03.016","article-title":"Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study","volume":"49","author":"Dai","year":"2008","journal-title":"J Hepatol"},{"key":"key20190422074157_b43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1475-097X.2012.01152.x","article-title":"Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature","volume":"32","author":"Roed","year":"2012","journal-title":"Clin Physiol Funct Imaging"},{"key":"key20190422074157_b44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2014.09.022","article-title":"Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study","volume":"62","author":"Hsu","year":"2015","journal-title":"J Hepatol"},{"key":"key20190422074157_b45","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"key20190422074157_b46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"key":"key20190422074157_b47","doi-asserted-by":"crossref","first-page":"e31527","DOI":"10.1371\/journal.pone.0031527","article-title":"Does hepatitis C virus infection increase risk for stroke? A population-based cohort study","volume":"7","author":"Liao","year":"2012","journal-title":"PLoS One"},{"key":"key20190422074157_b48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.289.10.1245-b","article-title":"Hepatitis C virus and atherosclerosis in patients with type 2 diabetes","volume":"289","author":"Fukui","year":"2003","journal-title":"JAMA"},{"key":"key20190422074157_b49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157016109787455707","article-title":"Infection, its treatment and the risk for stroke","volume":"7","author":"Palm","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"key":"key20190422074157_b50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med"},{"key":"key20190422074157_b51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/vim.2017.0009","article-title":"Hepatitis C virus-associated extrahepatic manifestations in lung and heart and antiviral therapy-related cardiopulmonary toxicity","volume":"30","author":"Ilyas","year":"2017","journal-title":"Viral Immunol"},{"key":"key20190422074157_b52","first-page":"RA55","article-title":"Hepatitis C associated cardiomyopathy: potential pathogenic mechanisms and clinical implications","volume":"14","author":"Sanchez","year":"2008","journal-title":"Med Sci Monit"},{"key":"key20190422074157_b53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/oxfordjournals.aje.a009302","article-title":"Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993","volume":"146","author":"Chambless","year":"1997","journal-title":"Am J Epidemiol"},{"key":"key20190422074157_b54","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0168-8278(17)30303-3","article-title":"HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohort","volume":"66","author":"Cacoub","year":"2017","journal-title":"J Hepatol"},{"key":"key20190422074157_b55","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1016\/S0168-8278(17)30882-6","article-title":"Risk of cardiovascular and cerebrovascular events in hepatitis C patients following completion of direct-acting antiviral therapy: a retrospective cohort study","volume":"66","author":"Singer","year":"2017","journal-title":"J Hepatol"},{"key":"key20190422074157_b56","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"key20190422074157_b57","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0168-8278(12)60007-5","article-title":"The interaction of metabolic factors with HCV infection: does it matter?","volume":"56","author":"Bugianesi","year":"2012","journal-title":"J Hepatol"},{"key":"key20190422074157_b58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhep.2018.02.015","article-title":"Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis","volume":"69","author":"Petta","year":"2018","journal-title":"J Hepatol"},{"key":"key20190422074157_b59","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1365-2893.2007.00885.x","article-title":"Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans","volume":"14","author":"Butt","year":"2007","journal-title":"J Viral Hepat"},{"key":"key20190422074157_b60","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"key20190422074157_b61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/519285","article-title":"Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV","volume":"196","author":"Letendre","year":"2007","journal-title":"J Infect Dis"},{"key":"key20190422074157_b62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s13365-014-0245-7","article-title":"Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18","volume":"20","author":"Liu","year":"2014","journal-title":"J Neurovirol"},{"key":"key20190422074157_b63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13365-011-0039-0","article-title":"Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling","volume":"17","author":"Paulino","year":"2011","journal-title":"J Neurovirol"},{"key":"key20190422074157_b64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","article-title":"Hepatitis C virus as a systemic disease: reaching beyond the liver","volume":"10","author":"Gill","year":"2016","journal-title":"Hepatol Int"},{"key":"key20190422074157_b65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"key20190422074157_b66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2006.10.009","article-title":"Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis","volume":"46","author":"Bonkovsky","year":"2007","journal-title":"J Hepatol"},{"key":"key20190422074157_b67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1478-3231.2011.02461.x","article-title":"Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study","volume":"31","author":"Marcellin","year":"2011","journal-title":"Liver Int"},{"key":"key20190422074157_b68","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key20190422074157_b69","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/apt.12485","article-title":"The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010","volume":"38","author":"Younossi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key20190422074157_b70","doi-asserted-by":"crossref","first-page":"e8340","DOI":"10.5812\/hepatmon.8340","article-title":"Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review","volume":"13","author":"Modabbernia","year":"2013","journal-title":"Hepat Mon"},{"key":"key20190422074157_b71","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.genhosppsych.2005.06.006","article-title":"Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors","volume":"27","author":"Golden","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"key20190422074157_b72","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gut.2006.100081","article-title":"Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?","volume":"55","author":"Forton","year":"2006","journal-title":"Gut"},{"key":"key20190422074157_b73","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.27422","article-title":"Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS)","volume":"61","author":"Boscarino","year":"2015","journal-title":"Hepatology"},{"key":"key20190422074157_b74","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jhep.2005.04.006","article-title":"Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial","volume":"43","author":"Fontana","year":"2005","journal-title":"J Hepatol"},{"key":"key20190422074157_b75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2002.30688","article-title":"Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease","volume":"35","author":"Forton","year":"2002","journal-title":"Hepatology"},{"key":"key20190422074157_b76","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01188.x","article-title":"Investigating health-related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients","volume":"17","author":"Lowry","year":"2010","journal-title":"J Viral Hepat"},{"key":"key20190422074157_b77","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","article-title":"Improved cognitive function as a consequence of hepatitis C virus treatment","volume":"8","author":"Thein","year":"2007","journal-title":"HIV Med"},{"key":"key20190422074157_b78","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s10620-006-9708-x","article-title":"Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection","volume":"52","author":"Kallman","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key20190422074157_b79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","article-title":"Fatigue in patients with chronic hepatitis C","volume":"9","author":"Poynard","year":"2002","journal-title":"J Viral Hepat"},{"key":"key20190422074157_b80","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(02)00067-3","article-title":"Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C","volume":"36","author":"Cacoub","year":"2002","journal-title":"J Hepatol"},{"key":"key20190422074157_b81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/etm.2014.1709","article-title":"Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients","volume":"8","author":"Mao","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20190422074157_b82","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0248-8663(00)88683-X","article-title":"Hepatitis C virus infection and thyroid diseases","volume":"20","author":"Broussolle","year":"1999","journal-title":"Rev Med Interne"},{"key":"key20190422074157_b83","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF03401317","article-title":"Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia","volume":"13","author":"Fallahi","year":"2014","journal-title":"Hormones (Athens)"},{"key":"key20190422074157_b84","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/archinte.164.21.2371","article-title":"Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study","volume":"164","author":"Bini","year":"2004","journal-title":"Arch Intern Med"},{"key":"key20190422074157_b85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15403\/jgld.2014.1121.252.chc","article-title":"Thyroid disturbance in patients with chronic hepatitis c infection: A systematic review and meta-analysis","volume":"25","author":"Shen","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"key20190422074157_b86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2110-5820-2-31","article-title":"Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis","volume":"2","author":"Zaidan","year":"2012","journal-title":"Ann Intensive Care"},{"key":"key20190422074157_b87","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","article-title":"Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease","volume":"167","author":"Tsui","year":"2007","journal-title":"Arch Intern Med"},{"key":"key20190422074157_b88","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2215\/CJN.00470107","article-title":"Hepatitis C virus infection and the prevalence of renal insufficiency","volume":"2","author":"Dalrymple","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20190422074157_b89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.20452\/pamw.953","article-title":"KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of mineral and bone disorders in chronic kidney disease","volume":"120","author":"Matuszkiewicz-Rowi\u0144ska","year":"2010","journal-title":"Pol Arch Med Wewn"},{"key":"key20190422074157_b90","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"key":"key20190422074157_b91","doi-asserted-by":"crossref","first-page":"J322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J Autoimmun"},{"key":"key20190422074157_b92","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4254\/wjh.v7.i1.78","article-title":"Hepatitis C and kidney disease: An overview and approach to management","volume":"7","author":"Azmi","year":"2015","journal-title":"World J Hepatol"},{"key":"key20190422074157_b93","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000335375","article-title":"Membranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits","volume":"35","author":"Bataille","year":"2012","journal-title":"Am J Nephrol"},{"key":"key20190422074157_b94","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20190422074157_b95","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/rmed.2003.1489","article-title":"Detection of HCV-RNA in bronchoalveolar lavage from a woman with pulmonary fibrosis","volume":"97","author":"Brunetti","year":"2003","journal-title":"Respir Med"},{"key":"key20190422074157_b96","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"key20190422074157_b97","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1586\/1744666X.2.5.801","article-title":"Relationship between hepatitis C virus infection and pulmonary disorders: potential mechanisms of interaction","volume":"2","author":"Kanazawa","year":"2006","journal-title":"Expert Rev Clin Immunol"},{"key":"key20190422074157_b98","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"key20190422074157_b99","first-page":"695","article-title":"Hepatitis C virus-related mixed cryoglobulinemia: pathogenesis, clinica manifestations, and new therapies","volume":"3","author":"Schamberg","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key20190422074157_b100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J Hepatol"},{"key":"key20190422074157_b101","first-page":"127","article-title":"Dermatologic extrahepatic manifestations of hepatitis C","volume":"3","author":"Dedania","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"key20190422074157_b102","first-page":"89","article-title":"Lichen planus and hepatitis C virus infection","volume":"48","author":"Gandolfo","year":"2002","journal-title":"Minerva Gastroenterol Dietol"},{"key":"key20190422074157_b103","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.3748\/wjg.v20.i24.7534","article-title":"Oral manifestations of hepatitis C virus infection","volume":"20","author":"Carrozzo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20190422074157_b104","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.4254\/wjh.v7.i27.2740","article-title":"Cutaneous manifestations of hepatitis C in the era of new antiviral agents","volume":"7","author":"Garcovich","year":"2015","journal-title":"World J Hepatol"},{"key":"key20190422074157_b105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1159\/000450679","article-title":"Use of direct-acting antivirals for the treatment of hepatitis C virus-associated oral lichen planus: A case report","volume":"10","author":"Misaka","year":"2016","journal-title":"Case Rep Gastroenterol"},{"key":"key20190422074157_b106","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.28422","article-title":"Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)","volume":"64","author":"Lawitz","year":"2016","journal-title":"Hepatology"},{"key":"key20190422074157_b107","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMc1101858","article-title":"Necrolytic acral erythema","volume":"364","author":"Kapoor","year":"2011","journal-title":"N Engl J Med"},{"key":"key20190422074157_b108","doi-asserted-by":"crossref","first-page":"740138","DOI":"10.1155\/2012\/740138","article-title":"Morphologic features of extrahepatic manifestations of hepatitis C virus infection","volume":"2012","author":"Ko","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"key20190422074157_b109","first-page":"1123","article-title":"Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C","volume":"17","author":"Tsoumani","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20190422074157_b110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0161-6420(94)31291-7","article-title":"Mooren-type hepatitis C virus-associated corneal ulceration","volume":"101","author":"Wilson","year":"1994","journal-title":"Ophthalmology"},{"key":"key20190422074157_b111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d\u2019Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l\u2019Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"key20190422074157_b112","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2018.1538790","article-title":"Uncommon immune-mediated extrahepatic manifestations of HCV infection","volume":"14","author":"Romano","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"key20190422074157_b113","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0168-8278(95)80461-7","article-title":"Absence of hepatitis C viral infection among patients with primary Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Marrone","year":"1995","journal-title":"J Hepatol"},{"key":"key20190422074157_b114","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13075-015-0766-3","article-title":"How hepatitis C virus modifies the immunological profile of Sj\u00f6gren syndrome: analysis of 783 patients","volume":"17","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"key20190422074157_b115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0004-27492013000200016","article-title":"Dry eye disease caused by viral infection: review","volume":"76","author":"Alves","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"key20190422074157_b116","first-page":"263","article-title":"Ophthalmological implications of the chronic infections with the hepatitis C Virus","volume":"59","author":"Anisia-Iuliana","year":"2015","journal-title":"Rom J Ophthalmol"},{"key":"key20190422074157_b117","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.57.12.728","article-title":"Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection","volume":"57","author":"Lee","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"key20190422074157_b118","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3899\/jrheum.081308","article-title":"Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study","volume":"36","author":"Guennoc","year":"2009","journal-title":"J Rheumatol"},{"key":"key20190422074157_b119","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/acr.22463","article-title":"Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection","volume":"67","author":"Patel","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key20190422074157_b120","first-page":"287","article-title":"Hepatitis C virus infection and its rheumatologic implications","volume":"10","author":"Sayiner","year":"2014","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key20190422074157_b121","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2017.03.004","article-title":"International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement","volume":"16","author":"Zignego","year":"2017","journal-title":"Autoimmun Rev"},{"key":"key20190422074157_b122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jtim-2017-0009","article-title":"Diagnosis and treatment of chronic hepatitis C with concomitant extrahepatic manifestations deserves a closer look","volume":"5","author":"Dou","year":"2017","journal-title":"J Transl Int Med"},{"key":"key20190422074157_b123","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/jir.2014.0200","article-title":"Clearance of hepatitis C virus improves insulin resistance during and after peginterferon and ribavirin therapy","volume":"35","author":"Chien","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"key20190422074157_b124","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jhep.2015.03.014","article-title":"Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir","volume":"63","author":"Younossi","year":"2015","journal-title":"J Hepatol"},{"key":"key20190422074157_b125","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/hep.28753","article-title":"Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia","volume":"64","author":"Gragnani","year":"2016","journal-title":"Hepatology"},{"key":"key20190422074157_b126","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cld.2017.03.015","article-title":"Treatment of extrahepatic manifestations of hepatitis C virus","volume":"21","author":"Degasperi","year":"2017","journal-title":"Clin Liver Dis"},{"key":"key20190422074157_b127","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"key":"key20190422074157_b128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"key20190422074157_b129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","article-title":"Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection","volume":"64","author":"Hsu","year":"2015","journal-title":"Gut"},{"key":"key20190422074157_b130","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1038\/ctg.2016.37","article-title":"Successful treatment of hepatitis C virus-associated oral lichen planus by interferon-free therapy with direct-acting antivirals","volume":"7","author":"Nagao","year":"2016","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2018.00049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:17:22Z","timestamp":1783707442000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2018.00049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":130,"journal-issue":{"issue":"X","published-online":{"date-parts":[[2019,4,21]]},"published-print":{"date-parts":[[2019,3,28]]}},"alternative-id":["10.14218\/JCTH.2018.00049"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2018.00049","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]}}}